Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CTSG | P08311 | 1/20 | 0.38 |
| ▸ | CTRC | Q99895 | 1/20 | 0.38 |
| ▸ | LPO | P22079 | 4/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | PDE4A | P27815 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10044418 | 0.87 | PDE4A (0.39) | MAPTALDH1A1GMNNLMNATHPO | |
| SCHEMBL14257134 | 0.84 | — | — | |
| SCHEMBL10436903 | 0.83 | LPO (0.34) | MAPTALDH1A1GMNNLMNATHPO | |
| SCHEMBL10072552 | 0.78 | GSK3A (0.34) | MAPTALDH1A1GMNNLMNATHPO | |
| SCHEMBL18686733 | 0.77 | TYR (0.41) | ALDH1A1BLMPMP22MGLLPDE4A | |
| SCHEMBL8388109 | 0.77 | LPO (0.30) | LPO | |
| SCHEMBL3584044 | 0.73 | HDAC6 (0.43) | ALDH1A1ELANELPOKDM4EKMT2A | |
| SCHEMBL24665500 | 0.73 | HSD17B13 (0.44) | ALDH1A1 | |
| SCHEMBL9802974 | 0.73 | HSD17B13 (0.41) | MAPTALDH1A1KDM4EMAPK1GSK3A | |
| SCHEMBL9248493 | 0.69 | LPO (0.52) | MAPTLMNALPOKDM4EGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10316111-B2 | Conjugated diene-based polymer, method for producing the same, and composition including the same | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2019-06-11 | — | — | US | claimed |
| CN-104744331-B | A kind of synthesis technique of Ezetimible intermediate | 浙江九洲药业股份有限公司 | 2018-05-15 | — | — | CN | claimed |
| CN-104744331-A | Synthetic process of ezetimibe intermediate | ZHEJIANG JIUZHOU PHARM CO LTD | 2015-07-01 | — | — | CN | claimed |
| CN-101284848-B | Synthetic method of clinic effect of alendronate | CSPC PHARMACEUTICAL GROUP OUYI PHARMA CO LTD | 2013-09-11 | — | — | CN | claimed |
| CN-102067358-A | Lithium cell with cathode containing iron disulfide | GILLETTE CO | 2011-05-18 | — | — | CN | claimed |
| CN-101630127-A | Photoresist stripper composition in fabrication of color filter array of liquid crystal display | DONGJIN SEMICHEM CO LTD | 2010-01-20 | — | — | CN | claimed |
| CN-101284848-A | Synthetic method of clinic effect of alendronate | SHIJIAZHUANG PHARM GROUP OUYI (CN) | 2008-10-15 | — | — | CN | claimed |
| EP-1601335-B1 | MEANS AND METHOD FOR THE SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBRES | WELLA AG (DE) | 2008-03-19 | — | — | EP | claimed |
| US-20060162096-A1 | Means and method for the simultaneous bleaching and dyeing of keratin fibres | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2006-07-27 | — | — | US | claimed |
| CN-1646732-A | Washing liquid | YIMOKE CHEMICAL SCIENCE AND TE (CN) | 2005-07-27 | — | — | CN | claimed |
| WO-2024101394-A1 | HYDROGENATED CONJUGATED DIENE POLYMER, AND HYDROGENATED CONJUGATED DIENE POLYMER MANUFACTURING METHOD | 旭化成株式会社 | 2024-05-16 | — | — | WO | disclosed |
| US-20230331894-A1 | Molded Bale | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2023-10-19 | — | — | US | disclosed |
| WO-2023171191-A1 | CONJUGATED DIENE POLYMER, CONJUGATED DIENE POLYMER COMPOSITION, AND CONJUGATED DIENE POLYMER CROSSLINKED PRODUCT | 旭化成株式会社 | 2023-09-14 | — | — | WO | disclosed |
| EP-4219191-A1 | BALE-MOLDED ARTICLE | Asahi Kasei Kabushiki Kaisha (JP) | 2023-08-02 | — | — | EP | disclosed |
| WO-2023038095-A1 | CROSSLINKED RUBBER COMPOSITION, METHOD FOR PRODUCING CROSSLINKED RUBBER COMPOSITION | 日本エラストマー株式会社 | 2023-03-16 | — | — | WO | disclosed |
| CN-1242363-A | Process for producing 1,3-dialkyl-2-imidazolidinone | MITSUI CHEMICALS INC (JP) | 2000-01-26 | — | — | CN | disclosed |
| CN-1214473-A | Use of pigment yellow 155 in electrophotographic toners and developers, powder coatings and inkjet inks | CLARIANT GMBH (DE) | 1999-04-21 | — | — | CN | disclosed |
| CN-1032534-C | Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase A2 inhibitor containing them | ISHIHARA SANGYO KAISHA (JP) | 1996-08-14 | — | — | CN | disclosed |
| CN-1120536-A | Preparation method of 1, 3-dialkyl-2-imidazolidinone | MITSUI TOATSU CHEMICALS (JP) | 1996-04-17 | — | — | CN | disclosed |
| CN-1058396-A | Diaminotrifluoromethderivatives derivatives and preparation method thereof and the phospholipase A that contains them 2Inhibitor | ISHIHARA SANGYO KAISHA (JP) | 1992-02-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060162096-A1 | Means and method for the simultaneous bleaching and dyeing of keratin fibres | KRT18, GPX4, NOX4 | MAPT 1718/4885ALDH1A1 727/4885GMNN 2381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.